{
    "title": "European drug panel recommends approving Novo Nordisk's new diabetes pill",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7952073/European-drug-panel-recommends-approving-Novo-Nordisks-new-diabetes-pill.html",
    "date": "2020-01-31",
    "keywords": [
        "treatment",
        "semaglutide",
        "recommendation",
        "approval",
        "quarter",
        "version",
        "jan",
        "panel",
        "regulator",
        "pill",
        "boosting",
        "drugmaker",
        "firstofakind",
        "agency",
        "httpswwwemaeuropaeuenmedicineshumansummariesopinionrybelsus",
        "committee",
        "chmp",
        "opinion",
        "type2",
        "form",
        "disease",
        "aversion",
        "commission",
        "couple",
        "company",
        "marketing",
        "authorization",
        "beginning",
        "producer",
        "brand",
        "name",
        "day",
        "exercise",
        "blood",
        "sugar",
        "class",
        "glp1",
        "insulin",
        "production",
        "hormone",
        "nordisk",
        "week",
        "rybelsus",
        "time",
        "fda",
        "brokerage",
        "pareto",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}